Rex Bionics PLC (LSE:RXB) - Overview

Stock Report

Rex Bionics PLC RXB

Last Price
GBX20.00

Day Change
-0.50|-2.44%

As of 02/12/2016
10:36:09 GMT | GBX
Minimum 15 Minutes Delay.

Last Close20.50p
Day Range18.00 - 18.00
Mkt Cap5.10Mil
52-Wk Range15.88 - 40.50
Yield %0.00
ISINGB00BLRLQM66
Volume5,555
P/E-0.69
P/S7.51
P/CF-0.93

Share Price

Total Returns 05/12/2016

 Chg (%)  
More ...
Rex Bionics PLC-11.11 
FTSE 100 TR GBP-1.21
 
Financials
201420152016
More ...
Income Statement
Turnover-0.130.45
Operating Profit--4.06-5.37
Net Profit--3.98-4.88
Reported EPS--40.11-28.80
Balance Sheet
Current Assets-5.082.73
Non Current Assets-14.0213.05
Total Assets-19.1015.78
Current Liabilities-0.600.92
Total Liabilities-3.463.46
Total Equity-15.6512.32
Cash Flow
Operating Cash Flow--3.63-3.71
Net Change in Cash-3.13-2.26
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-5.47-28.02--0.71---
2018--18.20--1.10---

Company Profile

Rex Bionics PLC is engaged in research & development, manufacturing and commercialisation of robotic devices designed to provide physiotherapy to and improve the physical and psychological well-being of people.
 

Sector

Medical Devices

Market Position

1619 of 1865 Companies

Index

Outlook

(26/08/2016) no outlook statement

Next Event 08/12/2016

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-0.9317.2116.27
Div Yld (E)0.002.024.36
PEG (E)0.001.490.00
ROCE-230.1933.3680.66
Op Mrgn-1,190.02-26.17-14.86
EPS Grwth0.0015.6125.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. David Macfarlane
Chief Executive OfficerMr. Crispin Simon
Chief Financial OfficerPeter Worrall
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.